Toll-like receptor 9 and 21 have different ligand recognition profiles and cooperatively mediate activity of CpG-oligodeoxynucleotides in zebrafish

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 51, 2013, Pages 20711-20716

  Yeh, Da Wei ^a,b   Liu, Yi Ling ^a   Lo, Yin Chiu ^a   Yuh, Chiou Hwa ^a   Yu, Guann Yi ^a   Lo, Jeng Fan ^c   Luo, Yunping ^d   Xiang, Rong ^e   Chuang, Tsung Hsien ^a,f  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^e NANKAI UNIVERSITY   (China)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adjuvant; Innate immunity; Pattern recognition receptor

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GENOMIC DNA; LIGAND; MEMBRANE RECEPTOR; TOLL LIKE RECEPTOR 21; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEVELOPMENTAL STAGE; EDWARDSIELLA TARDA; ENZYME ACTIVITY; IMMUNOSTIMULATION; LEUKOCYTE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; VIRUS INFECTION;

EID: 84890817605     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1305273110     Document Type: Article

References (46)

1. Tokunaga T, et al. (1984) Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG, I: Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 72(4):955-962.
2. Krieg AM, et al. (1995) CpG motifs in bacterial DNA trigger direct B-Cell activation. Nature 374(6522):546-549.
3. Sato Y, et al. (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273(5273):352-354.
4. Mutwiri G, et al. (2003) Biological activity of immunostimulatory CpG DNA motifs in domestic animals. Vet Immunol Immunopathol 91(2):89-103.
5. Chaung HC (2006) CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy. Int Immunopharmacol 6(10):1586-1596.
6. Carrington AC, Secombes CJ (2006) A review of CpGs and their relevance to aquaculture. Vet Immunol Immunopathol 112(3-4):87-101.
7. Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM (2011) CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 10(4):499-511.
8. Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709-760.
9. Pisetsky DS (2000) Mechanisms of immune stimulation by bacterial DNA. Springer Semin Immunopathol 22(1-2):21-33.
10. Kawai T, Akira S (2010) The role of pattern-Recognition receptors in innate immunity: Update on Toll-Like receptors. Nat Immunol 11(5):373-384.
11. Moresco EM, LaVine D, Beutler B (2011) Toll-Like receptors. Curr Biol 21(13): R488-R493.
12. Hemmi H, et al. (2000) A Toll-Like receptor recognizes bacterial DNA. Nature 408(6813):740-745.
13. Bauer S, et al. (2001) Human TLR9 confers responsiveness to bacterial DNA via speciesspecific CpG motif recognition. Proc Natl Acad Sci USA 98(16):9237-9242.
14. Chuang TH, Lee J, Kline L, Mathison JC, Ulevitch RJ (2002) Toll-Like receptor 9 mediates CpG-DNA signaling. J Leukoc Biol 71(3):538-544.
15. Akashi-Takamura S, Miyake K (2008) TLR accessory molecules. Curr Opin Immunol 20(4):420-425.
16. Lee CC, Avalos AM, Ploegh HL (2012) Accessory molecules for Toll-Like receptors and their function. Nat Rev Immunol 12(3):168-179.
17. Lee BL, et al. (2013) UNC93B1 mediates differential trafficking of endosomal TLRs. Elife 2:e00291.
18. Krieg AM (2006) Therapeutic potential of Toll-Like receptor 9 activation. Nat Rev Drug Discov 5(6):471-484.
19. Kanzler H, Barrat FJ, Hessel EM, Coffman RL (2007) Therapeutic targeting of innate immunity with Toll-Like receptor agonists and antagonists. Nat Med 13(5):552-559.
20. Kumagai Y, Takeuchi O, Akira S (2008) TLR9 as a key receptor for the recognition of DNA. Adv Drug Deliv Rev 60(7):795-804.
21. Haygreen L, Davison F, Kaiser P (2005) DNA vaccines for poultry: The jump from theory to practice. Expert Rev Vaccines 4(1):51-62.
22. Brownlie R, Allan B (2011) Avian toll-Like receptors. Cell Tissue Res 343(1):121-130.
23. Brownlie R, et al. (2009) Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides. Mol Immunol 46(15): 3163-3170.
24. Keestra AM, de Zoete MR, Bouwman LI, van Putten JP (2010) Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9. J Immunol 185(1):460-467.
25. Rebl A, Goldammer T, Seyfert HM (2010) Toll-Like receptor signaling in bony fish. Vet Immunol Immunopathol 134(3-4):139-150.
26. Palti Y (2011) Toll-Like receptors in bony fish: From genomics to function. Dev Comp Immunol 35(12):1263-1272.
27. Bell JK, et al. (2003) Leucine-Rich repeats and pathogen recognition in Toll-Like receptors. Trends Immunol 24(10):528-533.
28. Carpenter S, O'Neill LA (2009) Recent insights into the structure of Toll-Like receptors and post-Translational modifications of their associated signalling proteins. Biochem J 422(1):1-10.
29. Xu Y, et al. (2000) Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408(6808):111-115.
30. Blasius AL, Beutler B (2010) Intracellular toll-Like receptors. Immunity 32(3):305-315.
31. Macfarlane DE, Manzel L (1998) Antagonism of immunostimulatory CpG-Oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J Immunol 160(3):1122-1131.
32. Kim J, et al. (2013) Acidic amino acid residues in the juxtamembrane region of the nucleotide-Sensing TLRs are important for UNC93B1 binding and signaling. J Immunol 190(10):5287-5295.
33. Park SB, Aoki T, Jung TS (2012) Pathogenesis of and strategies for preventing Edwardsiella tarda infection in fish. Vet Res 43(1):67.
34. Pressley ME, Phelan PE, 3rd, Witten PE, Mellon MT, Kim CH (2005) Pathogenesis and inflammatory response to Edwardsiella tarda infection in the zebrafish. Dev Comp Immunol 29(6):501-513.
35. van der Vaart M, Spaink HP, Meijer AH (2012) Pathogen recognition and activation of the innate immune response in zebrafish. Adv Hematol 2012:159807.
36. Sullivan C, Kim CH (2008) Zebrafish as a model for infectious disease and immune function. Fish Shellfish Immunol 25(4):341-350.
37. Meijer AH, Spaink HP (2011) Host-Pathogen interactions made transparent with the zebrafish model. Curr Drug Targets 12(7):1000-1017.
38. Meijer AH, et al. (2004) Expression analysis of the Toll-Like receptor and TIR domain adaptor families of zebrafish. Mol Immunol 40(11):773-783.
39. Phelan PE, Mellon MT, Kim CH (2005) Functional characterization of full-Length TLR3, IRAK-4, and TRAF6 in zebrafish (Danio rerio). Mol Immunol 42(9):1057-1071.
40. Beutler B, et al. (2006) Genetic analysis of host resistance: Toll-Like receptor signaling and immunity at large. Annu Rev Immunol 24:353-389.
41. Lee MS, Kim YJ (2007) Signaling pathways downstream of pattern-Recognition receptors and their cross talk. Annu Rev Biochem 76:447-480.
42. O'Neill LA (2008) When signaling pathways collide: Positive and negative regulation of Toll-Like receptor signal transduction. Immunity 29(1):12-20.
43. Tabeta K, et al. (2006) The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-Like receptors 3, 7 andd. Nat Immunol 7(2): 156-164.
44. Matsuo A, et al. (2008) Teleost TLR22 recognizes RNA duplex to induce IFN and protect cells from birnaviruses. J Immunol 181(5):3474-3485.
45. Rankin R, et al. (2001) CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev 11(5):333-340.
46. Liu J, et al. (2012) Activation of rabbit TLR9 by different CpG-ODN optimized for mouse and human TLR9. Comp Immunol Microbiol Infect Dis 35(5):443-451.